Credit Suisse’s QIAGEN NV QGENF Stock Holding History
Bought
Maintained
Sold
Other funds holding QGENF
BJCM
PVI
GAM
BG
Credit Suisse's QGENF Position: Q1 2017 in Review
Credit Suisse sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 774,774 shares — an estimated $21.7M sold.
Credit Suisse first reported a position in QGENF in Q4 2013 and held it in 13 quarters. The position peaked at $57.8M in Q3 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.
- Credit Suisse reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
- Credit Suisse sold 774,774 QIAGEN NV shares in Q1 2017, an estimated $21.7M.
- Credit Suisse first reported a position in QIAGEN NV in Q4 2013 and held it in 13 quarters.
- Credit Suisse's QIAGEN NV position peaked at $57.8M in Q3 2014.
- 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.
Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.